Pharmo International (PMI) has taken a significant stride towards achieving a smoke-free future by becoming the sole owner of Swedish Match, a leading oral nicotine company.
Recently, one of the affiliated companies of Philip Morris International, Philip Morris Holland Holdings B.V. announced that it has acquired 93.11% of the shares of Swedish Match and intends to force the redemption of the remaining shares, and request that Swedish Match delist from the stock market.
Jacek Olczak, CEO of PMI International, has announced a welcoming of Swedish Match employees and their leading oral nicotine portfolio to the PMI family in order to create a global smoke-free champion. Of particular focus is the expansion of the IQOS and ZYN brands into the US and international markets. The company is excited about the growth, value creation, and progress in reducing tobacco harm and believes these advancements can be achieved together in the coming years.
PMI aims to replace cigarettes with scientifically advanced and more effective alternative smoking products as soon as possible.
By 2025, PMI aims to become a smoke-free company with over half of its total net revenue coming from a continuously growing portfolio of smoke-free alternatives.
Since 2008, PMI has invested over $9 billion in the research, development, and commercialization of smoke-free products and established world-class scientific evaluation capabilities, particularly in preclinical systematic toxicology, clinical and behavioral research, and post-market studies.
Swedish Match has made significant strides in its ongoing effort to reduce the harmful effects of tobacco with its line of smokeless products. Through strict regulatory pathways in the United States, the company has obtained authorization for some of its products and reshaped public health environments in countries such as Sweden and Norway.
As PMI continues to grow its business in the long term, these two companies represent a powerful combination focused on strategic vision, culture, and enterprise.
These companies will be able to jointly create a global, science-driven smoke-free future.
2FIRSTS will continue to monitor and report on this topic, with updates available on our '2FIRSTS APP'. Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
